Ipca Laboratories Limited

1,536.55

INR
+31.70(+2.11%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹39633.64 Cr
Enterprise Value
₹42193.56 Cr
P/E Ratio (TTM)
68.91
Forward P/E
33.19
PEG Ratio
33.19
Price to Sales (TTM)
4.83

Financial Metrics

Gross Margin
69.25%
Operating Margin
14.04%
Return on Equity
7.08%
Revenue (TTM)
₹8213.30 Cr+31.8%
EBITDA
₹1451.50 Cr
EPS (TTM)
₹22.67+18.099999999999998%

Balance Sheet

Total Cash
₹854.26 Cr
Total Debt
₹1438.36 Cr
Debt to Equity
18.61%

Stock Information

52 Week Range
₹966.4 - ₹1708.65
Beta
0.26
Shares Outstanding
₹25.37 Cr

Dividends & Splits

Forward Dividend Yield
0.50%
Trailing Dividend Yield
0.00%
Payout Ratio
8.80%

Ipca Laboratories Limited

1,536.55

INR
+31.70(+2.11%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹39633.64 Cr
Enterprise Value
₹42193.56 Cr
P/E Ratio (TTM)
68.91
Forward P/E
33.19
PEG Ratio
33.19
Price to Sales (TTM)
4.83

Financial Metrics

Gross Margin
69.25%
Operating Margin
14.04%
Return on Equity
7.08%
Revenue (TTM)
₹8213.30 Cr+31.8%
EBITDA
₹1451.50 Cr
EPS (TTM)
₹22.67+18.099999999999998%

Balance Sheet

Total Cash
₹854.26 Cr
Total Debt
₹1438.36 Cr
Debt to Equity
18.61%

Stock Information

52 Week Range
₹966.4 - ₹1708.65
Beta
0.26
Shares Outstanding
₹25.37 Cr

Dividends & Splits

Forward Dividend Yield
0.50%
Trailing Dividend Yield
0.00%
Payout Ratio
8.80%